Drägerwerk AG & Co. KGaA (pref) (F:DRW3) — Market Cap & Net Worth
Market Cap & Net Worth: Drägerwerk AG & Co. KGaA (pref) (DRW3)
Drägerwerk AG & Co. KGaA (pref) (F:DRW3) has a market capitalization of $895.84 Million (€766.26 Million) as of May 2, 2026. Listed on the F stock exchange, this Germany-based company holds position #9603 globally and #1166 in its home market, demonstrating a -6.99% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Drägerwerk AG & Co. KGaA (pref)'s stock price €89.10 by its total outstanding shares 8600000 (8.60 Million). Review DRW3 liabilities breakdown to assess the company's total debt and financial obligations.
Drägerwerk AG & Co. KGaA (pref) Market Cap History: 2015 to 2026
Drägerwerk AG & Co. KGaA (pref)'s market capitalization history from 2015 to 2026. Data shows growth from $666.32 Million to $895.84 Million (4.41% CAGR).
Drägerwerk AG & Co. KGaA (pref) Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Drägerwerk AG & Co. KGaA (pref)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.14x
Drägerwerk AG & Co. KGaA (pref)'s market cap is 0.14 times its annual revenue
Latest Price to Earnings (P/E) Ratio
3.77x
Drägerwerk AG & Co. KGaA (pref)'s market cap is 3.77 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $666.32 Million | $2.61 Billion | $33.58 Million | 0.26x | 19.85x |
| 2016 | $755.65 Million | $2.52 Billion | $82.08 Million | 0.30x | 9.21x |
| 2017 | $684.81 Million | $2.57 Billion | $98.47 Million | 0.27x | 6.95x |
| 2018 | $440.96 Million | $2.60 Billion | $34.35 Million | 0.17x | 12.84x |
| 2019 | $530.22 Million | $2.78 Billion | $33.35 Million | 0.19x | 15.90x |
| 2020 | $605.34 Million | $3.41 Billion | $250.16 Million | 0.18x | 2.42x |
| 2021 | $518.40 Million | $3.33 Billion | $154.23 Million | 0.16x | 3.36x |
| 2022 | $416.18 Million | $3.05 Billion | -$64.56 Million | 0.14x | N/A |
| 2023 | $496.32 Million | $3.37 Billion | $110.43 Million | 0.15x | 4.49x |
| 2024 | $468.53 Million | $3.37 Billion | $124.41 Million | 0.14x | 3.77x |
Competitor Companies of DRW3 by Market Capitalization
Companies near Drägerwerk AG & Co. KGaA (pref) in the global market cap rankings as of May 2, 2026.
Key companies related to Drägerwerk AG & Co. KGaA (pref) by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #140 globally with a market cap of $157.87 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #196 globally with a market cap of $120.60 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #234 globally with a market cap of $103.80 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #140 | Abbott Laboratories | NYSE:ABT | $157.87 Billion | $90.79 |
| #196 | Stryker Corporation | NYSE:SYK | $120.60 Billion | $315.13 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #234 | Medtronic PLC | NYSE:MDT | $103.80 Billion | $80.97 |
Drägerwerk AG & Co. KGaA (pref) Historical Marketcap From 2015 to 2026
Between 2015 and today, Drägerwerk AG & Co. KGaA (pref)'s market cap moved from $666.32 Million to $ 895.84 Million, with a yearly change of 4.41%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €895.84 Million | +28.76% |
| 2025 | €695.76 Million | +48.50% |
| 2024 | €468.53 Million | -5.60% |
| 2023 | €496.32 Million | +19.26% |
| 2022 | €416.18 Million | -19.72% |
| 2021 | €518.40 Million | -14.36% |
| 2020 | €605.34 Million | +14.17% |
| 2019 | €530.22 Million | +20.24% |
| 2018 | €440.96 Million | -35.61% |
| 2017 | €684.81 Million | -9.37% |
| 2016 | €755.65 Million | +13.41% |
| 2015 | €666.32 Million | -- |
End of Day Market Cap According to Different Sources
On May 1st, 2026 the market cap of Drägerwerk AG & Co. KGaA (pref) was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $895.84 Million USD |
| MoneyControl | $895.84 Million USD |
| MarketWatch | $895.84 Million USD |
| marketcap.company | $895.84 Million USD |
| Reuters | $895.84 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Drägerwerk AG & Co. KGaA (pref)
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas m… Read more